- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
T Rowe Price Health Sciences Fund Inc
+ Add to WatchlistPRHSX:US
50.52 USD 0.32 0.64%As of 09:29:30 ET on 05/17/2013.
Snapshot for T Rowe Price Health Sciences Fund Inc (PRHSX)
| Year To Date: | +22.56% | 3-Month: | +12.47% | 3-Year: | +26.68% | 52-Week Range: | 35.37 - 50.90 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +5.01% | 1-Year: | +40.76% | 5-Year: | +16.01% | Beta vs SPX: | 0.98 |
Fund Profile & Information for PRHSX
T. Rowe Price Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine or the life sciences.
| Inception Date: | 12-29-1995 | Telephone: | 1-800-225-5132 |
|---|---|---|---|
| Managers: | TAYMOUR R TAMADDON | ||
| Web Site: | www.troweprice.com | ||
Fundamentals for PRHSX
| NAV | (on 2013-05-17) 50.52 |
|---|---|
| Assets (M) | (on 2013-04-30) 6,514.87 |
| Fund Leveraged | N |
| Minimum Investment | 1,000.00 |
| Minimum Subsequent Investment | 100.00 |
Dividends for PRHSX
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-12-17) 0.14 |
| Dividend Yield (ttm) | 3.58 |
Fees & Expenses for PRHSX
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.65 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.00 |
| Expense Ratio | 0.79 |
Top Fund Holdings for PRHSX
Filing Date: 03/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 6,466,100 | 316,386,273 | 5.107% |
| Alexion Pharmaceuticals Inc | 3,278,600 | 302,090,204 | 4.876% |
| Catamaran Corp | 4,950,000 | 262,498,500 | 4.237% |
| Valeant Pharmaceuticals Intern | 2,450,000 | 183,799,000 | 2.967% |
| Pharmacyclics Inc | 2,125,000 | 170,871,250 | 2.758% |
| Incyte Corp Ltd | 5,290,000 | 123,838,900 | 1.999% |
| UnitedHealth Group Inc | 2,100,000 | 120,141,000 | 1.939% |
| Celgene Corp | 894,900 | 103,727,859 | 1.674% |
| Regeneron Pharmaceuticals Inc | 580,000 | 102,312,000 | 1.651% |
| Onyx Pharmaceuticals Inc | 1,105,000 | 98,190,300 | 1.585% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page